A full review of Alzheimer’s drug research, including current agents being studied for the prevention and treatment of the disease (and other dementias), emphasizes the need to develop and test drugs based on an understanding of the multiple effects of aging on the brain.
“Alzheimer’s is a complex disease with many different factors that contribute to its onset and progression,” said Dr. Howard Fillit, founding executive director and chief science officer of the Alzheimer’s Drug...
[Read More ...]
No comments:
Post a Comment